Amount Raised
$75 Million
Round Type
Series C
PleasantonBiotechnologyHealth CareScience And EngineeringInvestors
Description
IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative cell therapies and antibody products, today announced the completion of nearly US $75 million ($500 million RMB) in Series C1 funding. Eleven investment organizations participated in this investment round, including Shanghai Guoxin Investment & Development, Efung Capital, Shanghai Waigaoqiao Free Trade Zone Group, Nanjing Jiangbei New Area State-owned Asset Management, Housen Care Brothers, and Hongcheng Investment. The funding will support research and development of the company's pipeline products, and the commercial launch of its core product Equecabtagene Autoleucel.
Quick answer
Iaso Bio raised $75 Million in a Series C round, dated January 18, 2023. Investors: Hongcheng Investment, Housen Care Brothers, Nanjing Jiangbei New Area State Owned Asset Management, Shanghai Waigaoqiao Free Trade Zone Group, Efung Capital and Shanghai Guoxin Investment & Development. Iaso Bio is based in Pleasanton, California, United States.
- How much did Iaso Bio raise?
- Iaso Bio raised $75 Million in a Series C round on January 18, 2023.
- Who invested in Iaso Bio?
- Hongcheng Investment, Housen Care Brothers, Nanjing Jiangbei New Area State Owned Asset Management, Shanghai Waigaoqiao Free Trade Zone Group, Efung Capital and Shanghai Guoxin Investment & Development are named as investors in this round.
- What does Iaso Bio do?
- IASO Bio is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and autoimmune diseases.
- Where is Iaso Bio based and how big is it?
- Iaso Bio is based in Pleasanton, California, United States.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Iaso Bio that raised within 45 days of this round, from Fundz verified event records.
- 22nd Century raised $21M (Debt Financing) on March 3, 2023.
- Aprea Therapeutics raised an undisclosed amount (Funding Round) on February 28, 2023.
- Sorrento Therapeutics raised $75M (Funding Round) on February 21, 2023.
- Deka Biosciences, Inc. raised $30M on February 6, 2023.
- Garuda Therapeutics raised $62M on January 23, 2023.
- Wheeler Bio raised an undisclosed amount (Funding Round) on January 12, 2023.
Who to call at Iaso Bio, and when
A new round usually means Iaso Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Iaso Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Iaso Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Iaso Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Iaso Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Iaso Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.